Harbour BioMed, a global biopharmaceutical company, and Evinova, a global health-tech company, have entered a strategic ...
The U.S. Food and Drug Administration approved Johnson & Johnson’s drug Darzalex Faspro as the first treatment for adults with high-risk smoldering multiple myeloma, a precursor to the blood cancer.
Cytiva has launched the fibro dT platform for mRNA capture and purification processes.
Argonaut Manufacturing Services, a contract development manufacturing organization (CDMO) specializing in aseptic drug product manufacturing and the manufacturing of life science and diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback